Percutaneous coronary intervention of chronic saphenous vein graft occlusion: A potential new paradigm

Journal of Invasive Cardiology

Volumn 19, Issue 8, 2007, Pages

  Stathopoulos, Ioannis A ^a,b   Roubin, Gary S ^a  

^a LENOX HILL HEART AND VASCULAR INSTITUTE   (United States)

^b NEW YORK HOSPITAL QUEENS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANAMNESIS; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CHRONIC DISEASE; GRAFT OCCLUSION; GRAFT PATENCY; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERNAL MAMMARY ARTERY; LABORATORY TEST; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; PERCUTANEOUS CORONARY INTERVENTION; RIGHT CORONARY ARTERY; SAPHENOUS VEIN GRAFT; VASCULAR PATENCY; VEIN GRAFT DISEASE; CORONARY ARTERY BYPASS GRAFT; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; RADIOGRAPHY; SAPHENOUS VEIN; TRANSLUMINAL CORONARY ANGIOPLASTY; TRANSPLANTATION; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; SAPHENOUS VEIN; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 34548601402     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Eagle KA, Guyton RA, Davidoff R, et al. American College of Cardiology; American Heart Association. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
2. Morrison DS, Sethi G, Sacks J, et al. Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience for post-CABG patients. J Am Coll Cardiol 2002;40:1951-1954.
3. de Feyter P, Serruys P, van der Brand M, et al. Percutaneous transluminal angioplasty of a totally occluded bypass graft: A challenge that should be resisted. Am J Cardiol 1989;64:88-90.
4. Berger PB, Bell MR, Grill DE, et al. Influence of procedural success on immediate and long-term clinical outcome of patients undergoing percutaneous revascularization of occluded coronary artery bypass vein grafts. J Am Coll Cardiol 1996;28:1732-1737.
5. Khan KJ, Rutherford BD, McConahay DR, et al. Initial and long-term outcome of patients after balloon angioplasty of totally occluded bypass grafts. J Am Coll Cardiol 1994;23:1038-1042.
6. Lefkovits J, Holmes DR, Califf RM, et al. Predictors and sequelae of distal embolization during saphenous vein graft intervention from the CAVEAT-II trial. Coronary angioplasty versus excisional atherectomy trial. Circulation 1995;92:734-740.
7. Hartmann J, McKeever L, Teran J. Prolonged infusion or urokinase for recanalization of chronically occluded aortocoronary bypass graft. Am J Cardiol 1988;61:189-191.
8. Safian RD, Grines CL, May MA, et al. Clinical and angiographic results of transluminal extraction coronary atherectomy in saphenous vein bypass grafts. Circulation 1994;89:302-312.
9. Holmes DR Jr, Topol EJ, Califf RM, et al, for the CAVEAT-II investigators. A multicenter randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. Circulation 1995;91:1966-1974.
10. Bittl JA, Sanborn TA, Yardley DE, et al, for the Percutaneous Excimer Laser Coronary Angioplasty Registry. Predictors of outcome of percutaneous excimer laser coronary angioplasty of saphenous vein bypass graft lesions. Am J Cardiol 1994;74:144-148.
11. Singh M, Rosenschein U, Ho KK, et al. Treatment of saphenous vein bypass grafts with ultrasound thrombolysis: A randomized study (ATLAS). Circulation 2003;107:2331-2336.
12. Stankovic G, Colombo A, Presbitero P, et al, for the RECOVERS Investigators. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial. Circulation 2003;108:37-42.
13. Kuntz RE, Baim DS, Cohen DJ, et al, for the VeGAS 2 Investigators. A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (the Vein Graft AngioJet Study [VeGAS 2]). Am J Cardiol 2002;89:326-330,
14. Muramatsu T, Mitsudo K, Asakura Y, et al. Outcomes of CTO new technique for standard procedure trial (prospective multicenter registry in Japan: CONQUEST trial). Am J Cardiol 2004;94:76E.
15. Colombo P, Silva A, Delgado R, et al. Klugmann thrombus aspiration with the pronto extraction catheter before standard percutaneous coronary intervention improves myocardial reperfusion: Preliminary results of a prospective randomized study. Am J Cardiol 2004;94 (Suppl 6A):12E (abstract).
16. Whitlow PL, for the SECURITY investigators. SECURITY update presented at the Transcatheter Cardiovascular Therapeutics in Washington, DC, October 1, 2004.
17. Laham RJ, Carrozza JP, Berger C, et al. Long-term (4-6 year) outcome after Palmaz-Schatz stenting - Paucity of late stent-related problems. J Am Coll Cardiol 1996;28:820-826.
18. Ellis SG, Brener SJ, De Luca S, et al. Late myocardial ischemic events after saphenous vein graft intervention - Importance of initially "non-significant" vein graft lesions. Am J Cardiol 1997;79:1460-1464.
19. Price MJ, Sawhney N, Kao JA, et al. Clinical outcomes after sirolimus-eluting stent implantation for de novo saphenous vein graft lesions. Catheter Cardiovasc Interv 2005;65:208-211.
20. Tsuchida K, Ong AT, Aoki J, et al. Immediate and one-year outcome of percutaneous intervention of saphenous vein graft disease with paclitaxel-eluting stents. Am J Cardiol 2005;96:395-398.
21. Ge L, Iakovou I, Sangiorgi GM, et al. Treatment of saphenous vein graft lesions with drug-eluting stents: Immediate and midterm outcome. J Am Coll Cardiol 2005;45:989-994.